Announcements Trials

Browse Landscape

Phase

Status

Terminated 7 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Spondylitis, Ankylosing 1 Recurrence 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 Hand-Foot Syndrome 1 Endometrial Neoplasms 1 Colon Cancer Stage 1 Bile Duct Neoplasms 1

Interventions

Fluorouracil 18 Oxaliplatin 17 Capecitabine 16 Leucovorin 13 Cisplatin 12 Gemcitabine 11 Drug Therapy 11 Irinotecan 10 Radiosurgery 9 Cetuximab 9 Bevacizumab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Cyclophosphamide 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Celecoxib × Clear all

NCT03864575 2019-07-12

NICE-COMBO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡